Logo image of BCSF

BAIN CAPITAL SPECIALTY FINAN (BCSF) Stock Fundamental Analysis

USA - NYSE:BCSF - US05684B1070 - Common Stock

14.07 USD
+0.02 (+0.14%)
Last: 10/31/2025, 8:27:59 PM
14.07 USD
0 (0%)
After Hours: 10/31/2025, 8:27:59 PM
Fundamental Rating

4

Overall BCSF gets a fundamental rating of 4 out of 10. We evaluated BCSF against 237 industry peers in the Capital Markets industry. While BCSF is still in line with the averages on profitability rating, there are concerns on its financial health. BCSF is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year BCSF was profitable.
In the past year BCSF has reported a negative cash flow from operations.
Each year in the past 5 years BCSF has been profitable.
In multiple years BCSF reported negative operating cash flow during the last 5 years.
BCSF Yearly Net Income VS EBIT VS OCF VS FCFBCSF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

BCSF has a Return On Assets of 3.87%. This is comparable to the rest of the industry: BCSF outperforms 59.15% of its industry peers.
With a Return On Equity value of 9.44%, BCSF perfoms like the industry average, outperforming 53.19% of the companies in the same industry.
BCSF has a Return On Invested Capital (3.90%) which is comparable to the rest of the industry.
BCSF had an Average Return On Invested Capital over the past 3 years of 4.13%. This is below the industry average of 7.59%.
Industry RankSector Rank
ROA 3.87%
ROE 9.44%
ROIC 3.9%
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
BCSF Yearly ROA, ROE, ROICBCSF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

BCSF has a better Profit Margin (37.89%) than 80.43% of its industry peers.
BCSF's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 47.50%, BCSF belongs to the best of the industry, outperforming 82.55% of the companies in the same industry.
In the last couple of years the Operating Margin of BCSF has grown nicely.
BCSF has a Gross Margin of 51.17%. This is in the better half of the industry: BCSF outperforms 60.43% of its industry peers.
In the last couple of years the Gross Margin of BCSF has grown nicely.
Industry RankSector Rank
OM 47.5%
PM (TTM) 37.89%
GM 51.17%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
BCSF Yearly Profit, Operating, Gross MarginsBCSF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BCSF remains at a similar level compared to 1 year ago.
Compared to 5 years ago, BCSF has more shares outstanding
BCSF has a worse debt/assets ratio than last year.
BCSF Yearly Shares OutstandingBCSF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BCSF Yearly Total Debt VS Total AssetsBCSF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.60, we must say that BCSF is in the distress zone and has some risk of bankruptcy.
BCSF has a worse Altman-Z score (0.60) than 60.85% of its industry peers.
A Debt/Equity ratio of 1.37 is on the high side and indicates that BCSF has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.37, BCSF is doing worse than 66.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 0.6
ROIC/WACCN/A
WACCN/A
BCSF Yearly LT Debt VS Equity VS FCFBCSF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

BCSF has a Current Ratio of 1.63. This is a normal value and indicates that BCSF is financially healthy and should not expect problems in meeting its short term obligations.
BCSF has a Current ratio of 1.63. This is in the better half of the industry: BCSF outperforms 68.09% of its industry peers.
A Quick Ratio of 1.63 indicates that BCSF should not have too much problems paying its short term obligations.
BCSF's Quick ratio of 1.63 is fine compared to the rest of the industry. BCSF outperforms 68.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
BCSF Yearly Current Assets VS Current LiabilitesBCSF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

The earnings per share for BCSF have decreased by -5.16% in the last year.
BCSF shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.38% yearly.
Looking at the last year, BCSF shows a decrease in Revenue. The Revenue has decreased by -3.54% in the last year.
Measured over the past years, BCSF shows a quite strong growth in Revenue. The Revenue has been growing by 8.14% on average per year.
EPS 1Y (TTM)-5.16%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-7.84%
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-1.81%

3.2 Future

BCSF is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -10.18% yearly.
The Revenue is expected to decrease by -5.03% on average over the next years.
EPS Next Y-9.22%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
EPS Next 5YN/A
Revenue Next Year-4.16%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BCSF Yearly Revenue VS EstimatesBCSF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
BCSF Yearly EPS VS EstimatesBCSF Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.97 indicates a rather cheap valuation of BCSF.
Compared to the rest of the industry, the Price/Earnings ratio of BCSF indicates a rather cheap valuation: BCSF is cheaper than 85.96% of the companies listed in the same industry.
BCSF is valuated cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 8.45 indicates a reasonable valuation of BCSF.
Based on the Price/Forward Earnings ratio, BCSF is valued cheaper than 81.28% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BCSF to the average of the S&P500 Index (22.55), we can say BCSF is valued rather cheaply.
Industry RankSector Rank
PE 6.97
Fwd PE 8.45
BCSF Price Earnings VS Forward Price EarningsBCSF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BCSF Per share dataBCSF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as BCSF's earnings are expected to decrease with -10.18% in the coming years.
PEG (NY)N/A
PEG (5Y)1.3
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 11.96%, BCSF is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 8.40, BCSF pays a bit more dividend than its industry peers.
BCSF's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 11.96%

5.2 History

The dividend of BCSF has a limited annual growth rate of 2.77%.
BCSF has been paying a dividend for over 5 years, so it has already some track record.
BCSF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.77%
Div Incr Years3
Div Non Decr Years3
BCSF Yearly Dividends per shareBCSF Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

135.38% of the earnings are spent on dividend by BCSF. This is not a sustainable payout ratio.
BCSF's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP135.38%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
BCSF Yearly Income VS Free CF VS DividendBCSF Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M
BCSF Dividend Payout.BCSF Dividend Payout, showing the Payout Ratio.BCSF Dividend Payout.PayoutRetained Earnings

BAIN CAPITAL SPECIALTY FINAN

NYSE:BCSF (10/31/2025, 8:27:59 PM)

After market: 14.07 0 (0%)

14.07

+0.02 (+0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-10 2025-11-10/amc
Inst Owners33.3%
Inst Owner Change0.78%
Ins Owners0.63%
Ins Owner Change0%
Market Cap912.72M
Revenue(TTM)283.69M
Net Income(TTM)107.50M
Analysts77.78
Price Target16.49 (17.2%)
Short Float %0.84%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield 11.96%
Yearly Dividend1.77
Dividend Growth(5Y)2.77%
DP135.38%
Div Incr Years3
Div Non Decr Years3
Ex-Date12-16 2025-12-16 (0.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.14%
Min EPS beat(2)3.56%
Max EPS beat(2)4.72%
EPS beat(4)4
Avg EPS beat(4)4.81%
Min EPS beat(4)3.23%
Max EPS beat(4)7.71%
EPS beat(8)4
Avg EPS beat(8)1.22%
EPS beat(12)7
Avg EPS beat(12)7.05%
EPS beat(16)8
Avg EPS beat(16)5.98%
Revenue beat(2)1
Avg Revenue beat(2)-2.61%
Min Revenue beat(2)-7.71%
Max Revenue beat(2)2.49%
Revenue beat(4)2
Avg Revenue beat(4)-4.23%
Min Revenue beat(4)-12.42%
Max Revenue beat(4)2.49%
Revenue beat(8)4
Avg Revenue beat(8)-0.72%
Revenue beat(12)7
Avg Revenue beat(12)2.44%
Revenue beat(16)10
Avg Revenue beat(16)2.71%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.65%
EPS NY rev (1m)0%
EPS NY rev (3m)3.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.54%
Valuation
Industry RankSector Rank
PE 6.97
Fwd PE 8.45
P/S 3.22
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)2.02
EY14.36%
EPS(NY)1.67
Fwd EY11.84%
FCF(TTM)-2.5
FCFYN/A
OCF(TTM)-2.5
OCFYN/A
SpS4.37
BVpS17.56
TBVpS17.56
PEG (NY)N/A
PEG (5Y)1.3
Graham Number28.25
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 9.44%
ROCE 4.94%
ROIC 3.9%
ROICexc 3.96%
ROICexgc 3.98%
OM 47.5%
PM (TTM) 37.89%
GM 51.17%
FCFM N/A
ROA(3y)4.53%
ROA(5y)3.71%
ROE(3y)10.26%
ROE(5y)8.49%
ROIC(3y)4.13%
ROIC(5y)3.56%
ROICexc(3y)4.22%
ROICexc(5y)3.66%
ROICexgc(3y)4.24%
ROICexgc(5y)3.67%
ROCE(3y)5.23%
ROCE(5y)4.51%
ROICexgc growth 3Y15.38%
ROICexgc growth 5Y11.17%
ROICexc growth 3Y15.28%
ROICexc growth 5Y11.09%
OM growth 3Y2.21%
OM growth 5Y2.08%
PM growth 3Y-12.39%
PM growth 5Y-3.82%
GM growth 3Y2.62%
GM growth 5Y2.37%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.84
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z 0.6
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.16%
EPS 3Y15.4%
EPS 5Y5.38%
EPS Q2Q%-7.84%
EPS Next Y-9.22%
EPS Next 2Y-10.72%
EPS Next 3Y-10.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.54%
Revenue growth 3Y14.03%
Revenue growth 5Y8.14%
Sales Q2Q%-1.81%
Revenue Next Year-4.16%
Revenue Next 2Y-5.91%
Revenue Next 3Y-5.03%
Revenue Next 5YN/A
EBIT growth 1Y-4.73%
EBIT growth 3Y16.55%
EBIT growth 5Y10.39%
EBIT Next Year688.74%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.99%
OCF growth 3YN/A
OCF growth 5YN/A

BAIN CAPITAL SPECIALTY FINAN / BCSF FAQ

Can you provide the ChartMill fundamental rating for BAIN CAPITAL SPECIALTY FINAN?

ChartMill assigns a fundamental rating of 4 / 10 to BCSF.


Can you provide the valuation status for BAIN CAPITAL SPECIALTY FINAN?

ChartMill assigns a valuation rating of 5 / 10 to BAIN CAPITAL SPECIALTY FINAN (BCSF). This can be considered as Fairly Valued.


Can you provide the profitability details for BAIN CAPITAL SPECIALTY FINAN?

BAIN CAPITAL SPECIALTY FINAN (BCSF) has a profitability rating of 5 / 10.


Can you provide the financial health for BCSF stock?

The financial health rating of BAIN CAPITAL SPECIALTY FINAN (BCSF) is 2 / 10.


What is the expected EPS growth for BAIN CAPITAL SPECIALTY FINAN (BCSF) stock?

The Earnings per Share (EPS) of BAIN CAPITAL SPECIALTY FINAN (BCSF) is expected to decline by -9.22% in the next year.